In a report released today, David S Macdonald from SunTrust Robinson reiterated a Hold rating on Mednax Inc (MD), with a price target of $38. The company’s shares opened today at $34.50, close to its 52-week low of $31.68.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of 12.0% and a 62.3% success rate. Macdonald covers the Services sector, focusing on stocks such as American Renal Associates Holdings Inc, Fresenius Medical Care Corp, and Walgreens Boots Alliance.
Currently, the analyst consensus on Mednax Inc is a Hold with an average price target of $43.20, which is a 25.2% upside from current levels. In a report released today, Jefferies also downgraded the stock to Hold with a $36.50 price target.
.
See today’s analyst top recommended stocks >>
Mednax Inc’s market cap is currently $3.08B and has a P/E ratio of 9.30. The company has a Price to Book ratio of 1.02.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MEDNAX, Inc. provides physician services including newborn, anesthesia, maternal-fetal, tele radiology, pediatric cardiology and other pediatric subspecialty care. The company’s solution include anesthesiology & pain management, prenatal, neonatal, pediatric, radiology, tele radiology, revenue cycle management and perioperative improvement consulting.
